Increasing appropriate screening for colorectal cancer patients and their first degree relatives. A randomised controlled trial.

Completed

• Conditions: Colorectal Cancer; Cancer - Bowel - Back passage (rectum) or large bowel (colon); Cancer - Bowel - Anal; Cancer - Bowel - Small bowel (duodenum and ileum)

• Registration Number: ACTRN12609000628246
• Lead Sponsor: The University of Newcastle

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2009-07-28
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 4800

Inclusion Criteria

Index Cases - People who have received a confirmed diagnosis of bowel cancer no more than 6 months previously.

First degree relatives - Of people with bowel cancer particpating in the trial.

Exclusion Criteria

Index cases - People with familial adenomatous polyposis or hereditary non-polyposis colorectal cancer (HNPCC). Non-English speaking.

First-degree Relatives - Those with familial adenomatous polyposis or hereditary non-polyposis colorectal cancer (HNPCC), ulcerative colitis, Crohn’s disease, inflammatory bowel disease or a previous diagnosis of bowel cancer. Non-English speaking.

Study & Design

• Study Type: Interventional
• Study Design: Not specified